15 Dosell are Implemented in a New Municipality

2 years ago

STOCKHOLM, SWEDEN / ACCESSWIRE / March 21, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that the partner Zafe…

IRLAB Nominates New Candidate Drug, IRL757, to Treat Apathy in Neurological Disorders

2 years ago

GOTHENBURG, SWEDEN / ACCESSWIRE / March 21, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A) takes important steps…

Evotec Receives € 3 m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme

2 years ago

FIRST DOSING OF A STUDY PARTICIPANT TRIGGERS MILESTONE PAYMENT OF € 3 M TO EVOTECPHASE II CLINICAL TRIAL INITIATED BY…

Relief Therapeutics Appoints Christopher Wick as Senior Director, Head of U.S. Sales

2 years ago

Proven Pharmaceutical Sales Professional Brings Big Pharma Experience to Relief's U.S. Expansion ActivitiesGENEVA, SWITZERLAND / ACCESSWIRE / March 21, 2022…

Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission

2 years ago

GENEVA, SWITZERLAND / ACCESSWIRE / March 21, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), announced today that it has…

Moderna Announces New Supply Agreement for 2023 with Switzerland for Additional Seven Million Doses of Moderna’s COVID-19 Booster Vaccine

2 years ago

CAMBRIDGE, MA / ACCESSWIRE / March 21, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…

Athira Pharma Presents Study Overview and Baseline Data from ACT-AD Phase 2 Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease at the 2022 AD/PD™ Congress

2 years ago

BOTHELL, Wash., March 20, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on…

Core One Labs to Investigate Soliciting Investment and Potential Takeover Opportunities

2 years ago

VANCOUVER, British Columbia, March 19, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN:…

Advanced Proteome Therapeutics Announces Warrant Extension

2 years ago

Vancouver, British Columbia--(Newsfile Corp. - March 18, 2022) - Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) ("APC" or the "Company") announces that,…

Cloud DX Announces Closing of Private Placement

2 years ago

KITCHENER, ON / ACCESSWIRE / March 18, 2022 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF), a leading North American provider of virtual care…